The International Journal of the Cardiovascular Academy published data
from a pilot study using Cesca Therapeutics Inc.'s (Nasdaq: KOOL) technology
to treat acute myocardial infarction. The stock price more than doubled by leaping $2.11 to $4.12.
Data published on Cesca Therapeutics' technology
May 19, 2016 at 12:51 PM EDT